Article

Molecular Biological Determination of HER2 Status Using Both DNA and RNA Approaches. A Concordance Study with IHC Assessment

2024-12-03

Abstract excerpt

The ISH and IHC assays for assessing HER2 are now recommended by the American Society of Clinical Oncologists and the College of American Pathologists, but there are an increasing number of published studies describing alternative diagnoses at the molecular level. Inspired by these studies, we established a laboratory-developed test (LDT) to analyze HER2 status not only at the gene expression level but also at the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2994d156-11d4-5f98-a27c-dbd6876e0c18
DOI: 10.20944/preprints202412.0288.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular Biological Determination of HER2 Status Using Both DNA and RNA Approaches. A Concordance Study with IHC AssessmentDOI 10.20944/preprints202412.0288.v1Read

Detection of HER2 Status in Breast Cancer: Comparison of Current Methods with MLPA and Real-time RT-PCRSemantic proximity Read

Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic ConsiderationsSemantic proximity Read

Quantitative Assessment of HER2 Gene Amplification of Breast Cancer Using Droplet Digital PCRSemantic proximity Read

High Concordance Between Two Companion Diagnostics TestsSemantic proximity Read

Evaluation of the Quantitative Analytical Methods Real-Time PCR for HER-2 Gene Quantification and ELISA of Serum HER-2 Protein and Comparison with Fluorescence in Situ Hybridization and Immunohistochemistry for Determining HER-2 Status in Breast Cancer PatientsSemantic proximity Read

Gene Status in HER2 Equivocal Breast Carcinomas: Impact of Distinct Recommendations and Contribution of a Polymerase Chain Reaction-Based MethodSemantic proximity Read

Droplet digital PCR using HER2/EIF2C1 ratio for detection of HER2 amplification in breast cancer tissuesSemantic proximity Read

Real-Time Reverse Transcription-PCR Assay for Future Management of ERBB2-based Clinical ApplicationsSemantic proximity Read

Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.Semantic proximity Read

Evaluation of HER-2/neu Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer SpecimensSemantic proximity Read

Looking for more reliable biomarkers in breast cancer: Comparison between routine methods and RT-qPCRSemantic proximity Read

Validation of Dual-Color Dual In Situ Hybridization for HER2/neu Gene in Breast CancerSemantic proximity Read